Sedation during Awake Fiberoptic Intubation

A Comparative Study of Intravenous Dexmedetomidine¿versus Ketofol for Sedation during Awake Fiberoptic Intubation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201701001959580

Enrollment

Registered

2017-01-03

Start date

2016-06-25

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Surgery laryngeal mass

Interventions

dexmedetomidine

Ketofol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age 18-60 years old both sex ASA I,II and III Laryngeal mass biopsy under general anesthesia

Exclusion criteria

Exclusion criteria: Patient refusal Uncooperative patients. Emergency surgery Patients with hypersensitivity to any of drugs of the study. Addiction or patients on long term sedative medication. Pregnant women. 7- Body mass index more than 35 Kg/m2.

Design outcomes

Primary

Measure	Time frame
Haemodynamic variables and oxygen saturation	—

Countries

Egypt

Contacts

Public ContactMona Elghamry

drmonagh19802000@gmail.com01060101867

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026